The Hydroxymethylome of Multiple Myeloma Identifies FAM72D as a 1q21 Marker Linked to Proliferation

Haematologica - Italy
doi 10.3324/haematol.2019.222133
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ferrata Storti Foundation (Haematologica)

Related search

IL6R-STAT3-ADAR1 (P150) Interplay Promotes Oncogenicity in 1q21(amp) Multiple Myeloma

Haematologica
Hematology
2019English

Concomitant Gain of 1q21 and MYC Translocation Define a Poor Prognostic Subgroup of Hyperdiploid Multiple Myeloma

Haematologica
Hematology
2015English

Serological Normalisation as a Surrogate Marker for Minimal Residual Disease Negativity in Multiple Myeloma

British Journal of Haematology
Hematology
2018English

Bruceantin Inhibits Multiple Myeloma Cancer Stem Cell Proliferation

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2016English

Illegitimate WNT Signaling Promotes Proliferation of Multiple Myeloma Cells

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2004English

Serum Bone Sialoprotein as a Marker of Tumour Burden and Neoplastic Bone Involvement and as a Prognostic Factor in Multiple Myeloma

British Journal of Cancer
Cancer ResearchOncology
2001English

Exome Sequencing Identifies Germline Variants in DIS3 in Familial Multiple Myeloma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2019English

RNA Interference Screening Identifies Lenalidomide Sensitizers in Multiple Myeloma, Including RSK2

Blood
BiochemistryImmunologyCell BiologyHematology
2015English

Time to Plateau as a Predictor of Survival in Newly Diagnosed Multiple Myeloma

American Journal of Hematology
Hematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy